Wong Harry J, Su Bailey, Attaar Mikhail, Kuchta Kristine, Stearns Stephen, Linn John G, Haggerty Stephen P, Denham Woody, Ujiki Michael B
NorthShore University HealthSystem, Department of Surgery, Evanston, IL, USA.
University of Chicago Medicine, Department of Surgery, Chicago, IL, USA.
Surg Endosc. 2021 Dec;35(12):7174-7182. doi: 10.1007/s00464-020-08144-9. Epub 2020 Nov 25.
Anti-reflux mucosectomy (ARMS) is a new endoscopic procedure involving a hemi-circumferential endoscopic mucosal resection (EMR) around the gastroesophageal junction. We aim to compare perioperative and quality of life outcomes of patients with reflux who underwent ARMS to a comparable group who underwent laparoscopic Nissen fundoplication (NF).
A retrospective review of a prospectively maintained quality database was performed. All patients who underwent ARMS (n = 33) were matched with patients who underwent NF (n = 67). Clinical and quality of life (QOL) outcomes were collected preoperatively and up to two years postoperatively, measured by the Reflux Symptom Index (RSI), Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL), and Dysphagia Score. Outcomes were compared using the Wilcoxon rank-sum and Fisher's exact test.
While 10 patients (30.3%) who underwent ARMS required additional laparoscopic anti-reflux operations, the ARMS group had shorter OR time (p<0.001), less estimated blood loss (p<0.001), shorter hospital stay (p<0.001), less pain at discharge (p = 0.007), earlier narcotic discontinuation (p<0.001), and earlier return to activities of daily living (p<0.001) compared to the NF group. There was no difference in 30-day complication rates, emergency room visits, or readmission rates between the groups. There was no difference between ARMS and NF groups in terms of GERD-HRQL, RSI, or Dysphagia scores at 3 weeks, 6 months, 1 year, or 2 years postoperatively. However, the ARMS group reported less symptoms of gas and bloating postoperatively at all time points (all p<0.05). Both groups reported increased dysphagia at 3 weeks postoperatively (p<0.01) but this did not persist at 6 months, 1 year, or 2 years.
While ARMS had better perioperative outcomes compared to NF, reflux quality of life outcomes were comparable. ARMS can be an effective endoscopic intervention for GERD when performed on appropriately selected patients without limiting future laparoscopic anti-reflux interventions.
抗反流黏膜切除术(ARMS)是一种新的内镜手术,包括在胃食管交界处进行半周内镜黏膜切除术(EMR)。我们旨在比较接受ARMS的反流患者与接受腹腔镜Nissen胃底折叠术(NF)的可比组患者的围手术期和生活质量结果。
对前瞻性维护的质量数据库进行回顾性分析。所有接受ARMS的患者(n = 33)与接受NF的患者(n = 67)进行匹配。术前及术后长达两年收集临床和生活质量(QOL)结果,通过反流症状指数(RSI)、胃食管反流病健康相关生活质量(GERD-HRQL)和吞咽困难评分进行测量。使用Wilcoxon秩和检验和Fisher精确检验比较结果。
虽然10例接受ARMS的患者(30.3%)需要额外的腹腔镜抗反流手术,但与NF组相比,ARMS组手术时间更短(p<0.001),估计失血量更少(p<0.001),住院时间更短(p<0.001),出院时疼痛更轻(p = 0.007),更早停用麻醉剂(p<0.001),更早恢复日常生活活动(p<0.001)。两组间30天并发症发生率、急诊就诊率或再入院率无差异。术后3周、6个月、1年或2年时,ARMS组和NF组在GERD-HRQL、RSI或吞咽困难评分方面无差异。然而,ARMS组在所有时间点术后均报告较少的气体和腹胀症状(所有p<0.05)。两组均报告术后3周吞咽困难增加(p<0.01),但在6个月、1年或2年时未持续存在。
虽然与NF相比,ARMS的围手术期结果更好,但反流生活质量结果相当。当对适当选择的患者进行ARMS时,它可以是一种有效的GERD内镜干预方法,且不限制未来的腹腔镜抗反流干预。